Article
Liquid biopsy in liver cancer.
Discovery medicine - 1 Apr 2015
Labgaa Ismail, Villanueva Augusto
Abstract excerpt
Liver cancer has become the second cause of cancer-related death worldwide. Most patients are still diagnosed at intermediate or advanced stage, where potentially curative treatment options are not recommended. Unlike other solid tumors, there are no validated oncogenic addiction loops and the only systemic agent to improve survival in advanced disease is sorafenib. All phase 3 clinical trials testing molecular...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
